Sat, Mar 17, 2018
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index down 1.21% in March (-0.23% YTD); two-thirds of CTAs report losses

Tuesday, April 17, 2012
Opalesque Industry Update: Managed futures lost 1.21% in March according to the Barclay CTA Index compiled by BarclayHedge. The Index is down 0.23% after the first three months of 2012.

“Losses for March were widespread, as 66 percent of reporting managers ended the month in the loss column,” says Sol Waksman, founder and president of BarclayHedge.

“The river of red was wide, but fortunately it wasn’t deep.”

Six of Barclay’s eight CTA indices lost ground in March. The Barclay Diversified Traders Index dropped 1.85%, Systematic Traders were down 1.59%, Financial & Metals Traders lost 1.05%, and Currency Traders slipped 0.38%.

“US equity markets moved higher for another month, but gains from long positions in this sector were not enough to overcome losses in the other sectors,” says Waksman.

“Commodity prices moved lower on concerns of slowing in China, which in turn negatively impacted currencies of countries that are large exporters of commodities. Prices for US Treasuries also dropped in March.”

On the positive side of the ledger, the Barclay Agricultural Traders Index gained 1.80% in March, and Discretionary Traders added 0.39%.

“Discretionary traders are not as dependent on momentum driven trends as most other CTAs, and were able to eke out a profit in a difficult month,” says Waksman.

The Barclay BTOP50 Index, which measures performance of the largest CTAs, dropped 1.66% in March, cancelling out gains of 0.61% and 0.60% in the first two months of 2012. At the end of the first quarter, the BTOP50 is down 0.46%.


Press Release


What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Performance - Hedge fund mojo is back with investor hopes at six-year high, These hedge funds produce the most consistently great results[more]

    Hedge fund mojo is back with investor hopes at six-year high From Hedge funds on the heels of a surprisingly strong performance in 2017 are raising hopes for an encore. Investors expect their managers to return 8.5 percent in 2018, according to a Credit Suisse Group AG sur

  2. Investing - Hedge funds amass big bets against world's leading advertisers, Investor Elliott Management buys tiny stake in Wipro[more]

    Hedge funds amass big bets against world's leading advertisers From Hedge funds have amassed bearish bets of more than $3bn against the world's largest advertising companies in an attempt to profit as the industry undergoes ongoing wrenching disruption and slowing growth. Funds i

  3. News Briefs - Investcorp to launch a $100 million PE fund for Omani pension funds[more]

    Bahrain-based investment firm Investcorp will soon launch a $100 million fund dedicated to Oman's Pension Funds as part of its investment plan. 'The Opportunities Fund' will be focused on private equity investments in the U.S. and Europe and will target mid-sized companies across a broad range of se

  4. DoubleLine's Gundlach sees U.S. 10-year Treasury yield rising, weighing on stocks[more]

    From Reuters/ Jeffrey Gundlach, the chief executive of DoubleLine Capital and known on Wall Street as the "Bond King," said on Tuesday the yield on the U.S. 10-year Treasury note will likely move higher and pressure riskier assets including equities and junk bonds. Gundlach, on an

  5. SEC charges Theranos CEO Holmes with fraud[more]

    Bailey McCann, Opalesque New York: The SEC has charged Elizabeth Holmes, founder and CEO of Theranos and its former President Ramesh "Sunny" Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about t